Evidence map›Paper›PMID 36083398›Full record

ReviewNeurochemical research2023

Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.

Dmitry Lim, Laura Tapella, Giulia Dematteis, Maria Talmon, Armando A Genazzani

Open access · hybridFull text readReview
In one paragraph

Review in Neurochemical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Innovative approaches for the treatment of stroke: a recent update.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  11. Role of Calmodulin in Neurodegeneration and Neuroprotection.Mini reviews in medicinal chemistry · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Cells · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dmitry LimDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Via Bovio 6, 28100, Novara, Italy. dmitry.lim@uniupo.it.
Laura TapellaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Via Bovio 6, 28100, Novara, Italy.
Giulia DematteisDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Via Bovio 6, 28100, Novara, Italy.
Maria TalmonDepartment of Health Sciences, School of Medicine, Università del Piemonte Orientale "Amedeo Avogadro", Via Solaroli 17, 28100, Novara, Italy.
Armando A GenazzaniDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Via Bovio 6, 28100, Novara, Italy. armando.genazzani@uniupo.it.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

Fondazione Cariplo 2013-0795Fondazione Cariplo 2014-1094Fondazione CRT 1393-2017Università degli Studi del Piemonte Orientale FAR-2016
6 · The paper itself

Abstract

Calcineurin (CaN), a Ca

Indexed as

Alzheimer DiseaseAstrocytesCalcineurinHumansNeuroinflammatory DiseasesNeuronsCalcineurinAstrocytesCalcineurinEpilepsyMemoryNeuronal excitabilityProteostasis

Identifiers

PMID36083398
PMCPMC10030417
OpenAlexW4295023947

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.